Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Building Block for Growth

May 28th, 2009

Building Block for Growth

Abstract:
Recently celebrating its 25th anniversary, BFTP/SEP invests in innovative enterprises and creates commercialization pathways that generate wealth through science and technology. Part of a statewide network in Pennsylvania, BFTP/SEP has provided more than $130 million to grow more than 1,600 regional enterprises. BFTP/SEP is a founding partner of The Nanotechnology Institute, Mid-Atlantic Nanotechnology, the Emerald Stage2 Venture Fund and the Minority Angel Investor Network.

Among the BFTP-funded success stories is BioNanomatrix, which has pioneered technology enabling nanoscale investigation and analysis of genomic DNA. The Philadelphia-based company develops analytic and imaging platforms designed to dramatically reduce the time and cost needed to analyze DNA and other components of the genome. BioNanomatrix recently won the 2009 Frost & Sullivan Technology Innovation of the Year Award. The Frost & Sullivan Best Practices Awards identify companies, products, processes and executives that have achieved world-class performances.

BFTP invested $250,000 in BioNanomatrix in 2006, and in 2008 honored the company at the 14th Annual Ben Franklin Emerging Business Awards, known as the "Bennies," in which the company won the Best Management Team category.

BioNanomatrix's unique nanochannel array technology enables rapid and cost-effective analysis of the entire human genome, delivering single-molecule sensitivity in a massively parallel format for genetic diagnostics, personalized medicine and biomedical research applications.

BioNanomatrix recently received a Phase II grant from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH) to support further commercial development of the company's nanoscale whole genome imaging and analysis platform.

The 30-month, $2.08-million Small Business Investment Research (SBIR) award was made under the BioEngineering Nanotechnology Initiative, an interdisciplinary, multi-institute consortium with the stated goal of supporting the development of nanotechnologies critical for enabling essential breakthroughs that may have tremendous potential for affecting biomedicine.

"We are pleased that the NIH has again recognized the potential of our unique approach by awarding us this Phase II grant for the commercial development of our integrated nanoscale whole genome imaging and analysis platform," Dr. Michael Boyce-Jacino, president and CEO of BioNanomatrix, said.

"BioNanomatrix's nanoscale technology is intended to allow researchers to directly image and analyze very long, individual intact strands of DNA at the single-molecule level with very high resolution. [This yields] a great deal of genomic information that is not currently accessible...for a wide range of research and diagnostic applications," he added.

Source:
businessfacilities.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

BioNanomatrix

Related News Press

News and information

Quantum twisted Loong confirms the physical reality of wavefunctions September 23rd, 2017

Application of air-sensitive semiconductors in nanoelectronics: 2-D semiconductor gallium selenide in encapsulated nanoelectronic devices September 22nd, 2017

Researchers set time limit for ultrafast perovskite solar cells September 22nd, 2017

DNA triggers shape-shifting in hydrogels, opening a new way to make 'soft robots' September 21st, 2017

Investments/IPO's/Splits

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanometrics Announces Upcoming Investor Events August 3rd, 2017

Nanometrics to Participate in the 9th Annual CEO Investor Summit 2017: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2017 in San Francisco June 27th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Nanomedicine

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Graphene based terahertz absorbers: Printable graphene inks enable ultrafast lasers in the terahertz range September 13th, 2017

Applications for the nanomedTAB are open until September 18th, 2017 September 13th, 2017

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Magnetic cellular 'Legos' for the regenerative medicine of the future September 12th, 2017

Quantum detectives in the hunt for the world's first quantum computer September 8th, 2017

New results reveal high tunability of 2-D material: Berkeley Lab-led team also provides most precise band gap measurement yet for hotly studied monolayer moly sulfide August 26th, 2017

A more complete picture of the nano world August 24th, 2017

Nanobiotechnology

DNA triggers shape-shifting in hydrogels, opening a new way to make 'soft robots' September 21st, 2017

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Applications for the nanomedTAB are open until September 18th, 2017 September 13th, 2017

Magnetic cellular 'Legos' for the regenerative medicine of the future September 12th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project